FDA Announces Joint Meeting of Two Advisory Committees, Requests Public Comments

Summary

The Food and Drug Administration (FDA) is hosting a joint meeting of the Drug Safety and Risk Management Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee to provide advice on regulatory issues, with a public docket for comments.